Pharmala Biotech Stock Quote MDMA - Stock Price, News, Charts, Message Board, Trades

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
Canada
CSE
Pharmala Biotech Holdings Inc (MDMA) Quote

Pharmala Biotech Holdings Inc (MDMA)

0.27

0.01

(3.85%)

Closed February 05 4:00PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

0.27

Bid

0.255

Ask

0.275

Volume

266,593

0.25 Day's Range 0.29

0.065 52 Week Range 0.35

Previous Close

0.26

Open

0.26

Last Trade

Last Trade Time

Average Volume (3m)

369,998

Financial Volume

-

VWAP

-

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.04	17.3913043478	0.23	0.29	0.195	373269	0.22638057	CS
4	-0.02	-6.89655172414	0.29	0.31	0.195	248273	0.25797724	CS
12	-0.02	-6.89655172414	0.29	0.34	0.195	369998	0.27816794	CS
26	0.17	170	0.1	0.34	0.065	347785	0.21236773	CS
52	-0.03	-10	0.3	0.35	0.065	376847	0.20052802	CS
156	0.205	315.384615385	0.065	0.54	0.02	556823	0.19537326	CS
260	-0.17	-38.6363636364	0.44	0.54	0.02	561095	0.1919704	CS

MDMA - Frequently Asked Questions (FAQ)

What is the current Pharmala Biotech share price?

The current share price of Pharmala Biotech is $ 0.27

What is the 1 year trading range for Pharmala Biotech share price?

Pharmala Biotech has traded in the range of $ 0.065 to $ 0.35 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
QNTMQuantum BioPharma Ltd	$ 9.40 (104.35%)	84.09k
NWINuinsco Resources Limited	$ 0.01 (100.00%)	350k
CATCAT Strategic Metals Corporation	$ 0.01 (100.00%)	17k
VLTAVolta Metals Ltd	$ 0.07 (75.00%)	113.23k
NVRNorth Valley Resources Ltd	$ 0.07 (75.00%)	15k
VRNOVerano Holdings Corp	$ 1.77 (-71.99%)	3.95k
DOCTBeyond Medical Technologies Inc	$ 0.065 (-53.57%)	241.61k
MYCOMydecine Innovations Group Inc	$ 0.005 (-50.00%)	1.07k
AFXArctic Fox Lithium Corp	$ 0.005 (-50.00%)	4.77k
SUNNSolarBank Corporation	$ 4.76 (-35.59%)	700
WHIPCredissential Inc	$ 0.13 (30.00%)	4.92M
NTARNextech3D ai Corporation	$ 0.065 (30.00%)	3.28M
CCCCarlyle Commodities Corp	$ 0.02 (0.00%)	2.96M
CRVCCross River Ventures Corp	$ 0.005 (0.00%)	2.12M
GLMGolden Lake Exploration Inc	$ 0.05 (25.00%)	2.05M

lolroflmao

lolroflmao 3 months ago

PharmAla Reaches Agreement In Principle to Supply MDMA to Clinical Trial in Exchange for Full Data License

https://pharmala.ca/media/2024/11/pharmala-reaches-agreement-in-principle-to-supply-mdma-to-clinical-trial-in-exchange-for-full-data-license

lolroflmao

lolroflmao 3 months ago

News: PharmAla to supply LaNeo MDMA for Clinical Trial at Yale

https://pharmala.ca/media/2024/11/pharmala-to-supply-laneo-mdma-for-clinical-trial-at-yale

lolroflmao

lolroflmao 3 months ago

PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA Press Release | 10/21/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Mt-Sinai-Hospital-with-LaNeo-MDMA?id=456329

lolroflmao

lolroflmao 3 months ago

PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo™ MDMA Press Release | 10/08/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-the-University-of-Texas-San-Antonio-with-novel-dosage-form-of-LaNeo-MDMA?id=455196

lolroflmao

lolroflmao 3 months ago

PharmAla to supply Harvard Medical School’s Maclean Hospital with LaNeo MDMAPress Release | 10/02/2024
https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Harvard-Medical-Schools-Maclean-Hospital-with-LaNeo-MDMA?id=454666

lolroflmao

lolroflmao 3 months ago

PharmAla to supply Johns Hopkins Medicine for Clinical TrialPress Release | 09/11/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Johns-Hopkins-Medicine-for-Clinical-Trial?id=452770

Dewayne18

Dewayne18 2 years ago

$MDMA New Short Call: Shorts in at 30 cents today. Stay tuned tomorrow for details of its pending doom. Last call 34% in less than 2 days.

Dewayne18

Dewayne18 2 years ago

$MDMA SHORT ALERT!!!

Company up on lousy $50,000 deal.... Shorts in at 38 cents CDN.

Quick 30%

Act Now!!!

Dewayne18

Dewayne18 2 years ago

$MDMA is looking like the perfect short. The SP is racing up and the company only has 700K left with shares doubling up in the past 12 months. Over the past 12 months cash went down by 1.2 million.

Forcealpine

Forcealpine 3 years ago

It looks like this IPO has gone similarly to all psych companies have. The industry needs a massive correction, but that cannot happen until government stop obsessing over vaccines and start promoting alternative solutions to the gigantic mental health crisis ongoing and perpetuating daily while being ignored. MDMA looks promising and I'll be keeping a very close eye on its news and resulting share price.

Pharmala Biotech

Delayed Upgrade Clock